Drinking causes 1 in every 20 deaths worldwide. Perversely, because its harms are so widespread and longstanding and well ...
Few substances are as deeply woven into everyday life as alcohol. It is a fixture at holiday celebrations, work-related ...
(Left:) Stock image of Ozempic; (Right:) Stock image of someone taking a bottle of alcohol off a shelf. It has been theorized that Ozempic could potentially help with substance abuse disorders due to ...
Semaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and consumption in a small trial involving people with moderate alcohol use disorder ...
A new study shows that cannabidiol (CBD) can reduce the craving for alcohol in people suffering from alcoholism. CBD is a natural component of the cannabis plant and has no intoxicating effects.
Could drugs like Ozempic help curb heavy drinking? Image credit: Viktor Solomin/Stocksy. Despite the availability of treatment options, past research shows that fewer than 10% of people with AUD ...
A medication that’s made headlines for its weight loss effects might hold another life-changing secret. New research suggests that semaglutide, the active ingredient in popular medications Ozempic and ...
Add Yahoo as a preferred source to see more of our stories on Google. The study was relatively small and involved 48 people who showed signs of moderate AUD who weren’t seeking treatment. Each female ...
A new study conducted by researchers from the University of Southern California looked at a positive side effect of drugs like Ozempic and Wegovy – a reduction in alcohol consumption. Their work found ...
The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research. The findings, ...
Once-weekly subcutaneous injections of semaglutide (Ozempic, Novo Nordisk) reduced alcohol cravings and consumption in adults with alcohol use disorder (AUD), findings from a small phase 2 ...